Pharmaceutical Raw Materials,Plant Extracts,Peptides Manufacturer & Supplier: TCS Group.

Company News

an investigational drug developed for the treatment of asthma and scalp hair loss

an investigational drug developed for the treatment of asthma and scalp hair loss

setipiprant (inn; developmental code names act-129968, kyth-105) is an investigational drug developed for the treatment of asthma and scalp hair loss. it was originally developed by actelion and acts as a selective, orally available antagonist of the prostaglandin d2 receptor 2 (dp2). the drug is being developed as a novel treatment for male pattern baldness by allergan.

medical uses
scalp hair loss
acting through dp2, pgd2 can inhibit hair growth, suggesting that this receptor is a potential target for bald treatment. a phase 2a study to evaluate the safety, tolerability, and efficacy of oral setipiprant relative to a placebo in 18- to 49-year-old males with androgenetic alopecia was compl

we are API powder supplier of setipiprant from china.

https://www.tcsindustry.com/pro/seripiprant_866460-33-5_hair_loss_seripiprant_powder_buy_seripiprant_topical.html


Latest News

Contact Us

Tel:+86(510)88771160

Fax:+86(510)82177481

Email:[email protected]

ADD: Room C405, No. 488,Cuishan Rd, Xishan District, Wuxi City, Jiangsu China